Reply to S. Fuji

Andreas Burchert¹, Stephan K Metzelder¹, Andreas Neubauer¹, Michael Wittenberg¹, Carmen Schade-Brittinger¹

Affiliations

Affiliation

¹ Andreas Burchert, MD, Stephan K. Metzelder, MD, and Andreas Neubauer, MD, Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany and Michael Wittenberg, PhD, and Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University Marburg, Marburg, Germany.

PMID: 33621111
DOI: 10.1200/JCO.20.02891

Comment

Reply to S. Fuji

Andreas Burchert et al. J Clin Oncol. 2021.

. 2021 Apr 20;39(12):1412-1413.

doi: 10.1200/JCO.20.02891. Epub 2021 Feb 23.

Authors

Andreas Burchert¹, Stephan K Metzelder¹, Andreas Neubauer¹, Michael Wittenberg¹, Carmen Schade-Brittinger¹

Affiliation

¹ Andreas Burchert, MD, Stephan K. Metzelder, MD, and Andreas Neubauer, MD, Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany and Michael Wittenberg, PhD, and Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University Marburg, Marburg, Germany.

PMID: 33621111
DOI: 10.1200/JCO.20.02891

No abstract available

PubMed Disclaimer

Conflict of interest statement

Andreas BurchertHonoraria: Bristol-Myers Squibb, Novartis, AOP Orphan PharmaceuticalsConsulting or Advisory Role: Pfizer, Gilead SciencesResearch Funding: Novartis, AOP Orphan PharmaceuticalsAndreas NeubauerSpeakers' Bureau: MedupdateTravel, Accommodations, Expenses: Gilead SciencesNo other potential conflicts of interest were reported.

Comment on

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN).
Burchert A, Bug G, Fritz LV, Finke J, Stelljes M, Röllig C, Wollmer E, Wäsch R, Bornhäuser M, Berg T, Lang F, Ehninger G, Serve H, Zeiser R, Wagner EM, Kröger N, Wolschke C, Schleuning M, Götze KS, Schmid C, Crysandt M, Eßeling E, Wolf D, Wang Y, Böhm A, Thiede C, Haferlach T, Michel C, Bethge W, Wündisch T, Brandts C, Harnisch S, Wittenberg M, Hoeffkes HG, Rospleszcz S, Burchardt A, Neubauer A, Brugger M, Strauch K, Schade-Brittinger C, Metzelder SK. Burchert A, et al. J Clin Oncol. 2020 Sep 10;38(26):2993-3002. doi: 10.1200/JCO.19.03345. Epub 2020 Jul 16. J Clin Oncol. 2020. PMID: 32673171 Clinical Trial.
How Can We Distinguish Sorafenib-Associated Skin Rash From Skin Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell Transplantation?
Fuji S. Fuji S. J Clin Oncol. 2021 Apr 20;39(12):1412. doi: 10.1200/JCO.20.02228. Epub 2021 Feb 23. J Clin Oncol. 2021. PMID: 33621112 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to S. Fuji

Affiliation

Reply to S. Fuji

Authors

Affiliation

Conflict of interest statement

Comment on

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources